This educational activity is designed for advanced practice registered nurses, nurse practitioners and other nursing professionals, physicians, pharmacists, physician associates/assistants, and dietitians.
After participating in this activity, learners should be better able to:
Examine how different pharmacologic agents affect wounds and their healing processes
Summarize adjunctive therapies that may be used in conjunction with medication therapy for acute and chronic wounds
Identify methods for managing soft tissue and bone infections, bioburden, and local and systemic infections
Employ an appropriate therapeutic regimen that maximizes therapeutic effectiveness while minimizing adverse reactions
The activity is best supported via a computer or device with a current version of one of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print content.
This on-demand webcast is available with synchronized slides and video/audio.
To be eligible for documentation of credit for each session attended, learners must participate in the activity and complete the activity evaluation. Participants who complete the evaluation online within the active dates of the training will receive documentation of credit. Your certificate may not load if you are accessing it from a smartphone, or settings of your browser do not allow for a new tab/window to open.
Once a certificate has been claimed, physicians and pharmacists may elect for credits to be submitted on their behalf to their boards via additional fields that will appear within the Claim Certificate page. Credits must be submitted through this process to be reported to the American Board of Surgery and the National Association of Boards of Pharmacy.
Release Date: March 2, 2026
Expiration Date: March 2, 2028
Estimated Time to Complete: 41.75 hours
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. See below for full accreditation details, including credit types and totals, for this activity.
HMP Education designates this enduring activity for 41.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring, knowledge-based activity (Universal Activity Number JA0006201-0000-26-090-H01-P) has been approved for 41.75 contact hours (4.175 CEUs).
Note: The certificate is not the official record of your participation in the activity. The official record of credit will be the information in the CPE Monitor system. Following ACPE Policy, credit must be transmitted to NABP through CPE Monitor within 60 days from the date you complete this CPE activity.
This continuing nursing education enduring activity awards 41.75 contact hours.
Provider approved by the California Board of Registered Nursing, Provider #18006 for 41.75 contact hours.
This activity will also award 25.00 pharmacotherapeutic contact hours.
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This enduring activity is designated for 41.75 AAPA Category 1 credits. Approval is valid until March 2, 2028. PAs should claim only the credit commensurate with the extent of their participation.
Dietitians
Visit this link for Countries and Regions have reciprocity with the ACCME.
Visit this link for additional countries that accept ACCME-accredited continuing medical education (CME).
HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real relevant financial relationship (conflicts of interest) between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME and CPME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
Any investigational, off-label, or non-FDA approved content or discussion.
HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified financial relationships (conflicts of interest), and ensure:
All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
All relevant financial relationships have been mitigated.
The faculty has reported the following:
Maria T. Abreu: AbbVie Inc.: Advisory Board; AbbVie Inc.: Consultant; Amgen: Advisory Board; Amgen: Consultant; Bristol Myers Squibb: Advisory Board; Bristol Myers Squibb: Consultant; Celsius Therapeutics: Advisory Board; Celsius Therapeutics: Consultant; Eli Lilly and Company: Advisory Board; Eli Lilly and Company: Consultant; Gilead Sciences: Advisory Board; Gilead Sciences: Consultant; Janssen Pharmaceuticals: Advisory Board; Janssen Pharmaceuticals: Consultant; Microba Life Sciences: Advisory Board; Microba Life Sciences: Consultant; Pfizer Pharmaceutical: Advisory Board; Pfizer Pharmaceutical: Consultant; Prometheus Biosciences: Advisory Board; Prometheus Biosciences: Consultant; UCB Biopharma SRL: Advisory Board; UCB Biopharma SRL: Consultant
Karen L. Bauer: Urgo Medical: Consultant
Janice M. Beitz: ConvaTec: Consultant; ConvaTec: Grant/Research Support
Rick Bernstein: Cardiovascular Systems, Inc.: Consultant
Margaret Bobonich: Dermavant Sciences, Inc.: Advisory Board; Dermavant Sciences, Inc.: Speakers Bureau; Incyte: Advisory Board; Regeneron/Sanofi: Speakers Bureau; Takeda Pharmaceuticals U.S.A.: Advisory Board; UCB Inc.: Advisory Board
Heidi H. Cross: Has Nothing to Disclose.
Vickie R. Driver: Has Nothing to Disclose.
Scott Elman: Has Nothing to Disclose.
Daniel G. Federman: Has Nothing to Disclose.
Phyllis Famularo: Has Nothing to Disclose.
Matthew Finnegan: Has Nothing to Disclose.
Maria Goddard: Medline: Advisory Board; Medline: Consultant; Medline: Speakers Bureau; Radiometer: Other Financial or Material Support; vTail: Consultant
Duane R. Hospenthal: Has Nothing to Disclose.
Jose A. Jaller: Hoth Therapeutics: Other Financial or Material Support; InflaRX: Other Financial or Material Support
Warren S. Joseph: Paratek Pharma: Speakers Bureau
Keith Kaye: Carb-X: Consultant; GSK: Consultant; Meiji: Advisory Board; Merck: Consultant; AbbVie: Consultant; Shionogi: Consultant
Robert S. Kirsner: Pfizer: Consultant; Pfizer: Grant/Research Support; Smith & Nephew: Consultant
Daniela Kroshinsky: Has Nothing to Disclose.
Kathryn Evans Kreider: Novo Nordisk: Advisory Board; Novo Nordisk: Speakers Bureau
Jeffrey Kwong: Has Nothing to Disclose.
Loan Lam: AOTI: Speakers Bureau; Hartmann: Consultant; Hartmann: Speakers Bureau; LifeNet Health: Consultant; LifeNet Health: Speakers Bureau; Organogenesis: Speakers Bureau; Paratek Pharma: Speakers Bureau; Urgo Medical: Consultant
Edward V. Loftus, Jr.: AbbVie Inc.: Consultant; AbbVie Inc.: Grant/Research Support; Alvotech: Consultant; Amgen: Consultant; Arena Pharmaceuticals: Consultant; Avalo Therapeutics: Advisory Board; Boehringer Ingelheim: Consultant; Bristol Myers Squibb: Advisory Board; Bristol Myers Squibb: Grant/Research Support; Celltrion Healthcare Co. Ltd.: Consultant; Eli Lilly & Company: Consultant; Exact Sciences: Other Financial or Material Support; Fresenius Kabi: Consultant; Genentech-Roche: Grant/Research Support; Gilead Sciences: Consultant; Gilead Sciences: Grant/Research Support; GlaxoSmithKline: Consultant; Gossamer Bio: Consultant; Gossamer Bio: Grant/Research Support; Iota Bioscience: Consultant; Iterative Health: Consultant; Janssen Biotech: Consultant; KSL Diagnostics: Consultant; Morphic Therapeutic: Consultant; Ono Pharmaceutical Co., Ltd.: Consultant; Protagonist Therapeutics: Consultant; Scipher Medicine: Consultant; SLACK Inc./Healio Gastroenterology: Other Financial or Material Support; Sun Pharmaceuticals Industry Ltd.: Consultant; Surrozen: Consultant; Takeda Pharmaceuticals U.S.A.: Consultant; Takeda Pharmaceuticals U.S.A.: Grant/Research Support; Theravance Biopharma: Grant/Research Support
Millie D. Long: Bristol Myers Squibb: Consultant; Calibr: Consultant; Janssen Biotech: Consultant; Lilly Pharmaceuticals: Consultant; Pfizer, Inc.: Consultant; Pfizer, Inc.: Grant/Research Support; Prometheus Biosciences: Consultant; Roche Genentech: Consultant; Takeda Pharmaceuticals U.S.A.: Consultant; Takeda Pharmaceuticals U.S.A.: Grant/Research Support; TARGET RWE: Consultant
Andrea Maderal: Argenx: Consultant
Brian McDermott: Has Nothing to Disclose.
Kristin Mondy: Has Nothing to Disclose.
Christine Murphy: 3M/KCI: Advisory Board; 3M/KCI: Consultant; 3M/KCI: Speakers Bureau; ConvaTec: Advisory Board; ConvaTec: Consultant; ConvaTec: Speakers Bureau; Urgo: Advisory Board
Harikrshna KR Nair: Has Nothing to Disclose.
Mary Anne R. Obst: 3M Health Care (Medical Solutions Division): Speakers Bureau; Fistula Solution: Patent Holder; KCI: Speakers Bureau; Urgo Medical: Speakers Bureau
Alex Ortega Loayza: AbbVie Inc.: Grant/Research Support; Boehringer Ingelheim: Advisory Board; Bristol-Myers Squibb: Advisory Board; Corvus Pharma: Consultant; Eli Lilly Pharmaceuticals: Grant/Research Support; Genetech: Consultant; Guidepoint Global: Consultant; Janssen Biotech: Advisory Board; Janssen Biotech: Grant/Research Support; Pfizer, Inc.: Grant/Research Support
Irena Pastar: Has Nothing to Disclose.
Julia C. Paul: Has Nothing to Disclose.
Rick Pope: Has Nothing to Disclose.
Lee C. Rogers: American Board of Podiatry Medicine: Board of Directors; American Board of Podiatry Medicine: Other Financial or Material Support; Amputation Prevention Experts (APEx) Health Network: Other Financial or Material Support; CarePICS: Advisory Board; ETS Wound Care: Grant/Research Support; Integra LifeSciences: Consultant; Kent Imaging: Grant/Research Support; Kerecis, LLC: Advisory Board; Kerecis LLC: Grant/Research Support; MISONIX-SOLSYS: Consultant; University of Texas: Other Financial or Material Support
Lee C. Ruotsi: Mölnlycke Health Care: Consultant; Mölnlycke Health Care: Speakers Bureau; Smith & Nephew: Advisory Board; Smith & Nephew: Consultant; Smith & Nephew: Speakers Bureau
David T. Rubin: AbbVie Inc.: Advisory Board; AbbVie Inc.: Consultant; Abgenomics/Altrubio: Consultant; Alimentiv Inc.: Consultant; Amgen: Consultant; Avalo Therapeutics: Consultant; Bristol Myers Squibb: Advisory Board; Bristol Myers Squibb: Consultant; Buhlmann Diagnostics Corp: Consultant; ClostraBio: Consultant; Connect BioPharma: Consultant; Datos Health Ltd.: Consultant; EcoR1: Consultant; Eli Lilly and Co.: Consultant; Evinature, Ltd.: Consultant; Ferring Pharmaceuticals: Consultant; Genentech Inc.: Consultant; Gilead Sciences: Consultant; Image Analysis Group: Consultant; Iterative Health: Advisory Board; Iterative Health: Consultant; Janssen Pharmaceuticals: Advisory Board; Janssen Pharmaceuticals: Consultant; Menten AI: Consultant; Neurological Corp., a subsidiary of Samsung Electronics Co., Ltd.: Consultant; Odyssey Thera: Consultant; Pfizer: Consultant; Prometheus Biosciences: Consultant; Reistone Biopharma: Consultant; Sangamo: Consultant; Shanghai Pharma Biotherapeutics USA: Consultant; Takeda Pharmaceuticals U.S.A.: Advisory Board; Takeda Pharmaceuticals U.S.A.: Consultant; Takeda Pharmaceuticals U.S.A.: Grant/Research Support; Target RWE: Consultant; Tissium: Consultant; Trellus Health: Consultant
Bruce E. Sands: AbbVie Inc.: Consultant; Amgen: Consultant; AstraZeneca: Consultant; Boehringer-Ingelheim: Consultant; Bristol Myers Squibb: Consultant; Bristol Myers Squibb: Grant/Research Support; Bristol Myers Squibb: Speakers Bureau; Celltrion: Consultant; Eli Lilly & Company: Consultant; Fresenius Kabi: Consultant; Genentech: Consultant; Glaxo SmithKline: Consultant; Janssen: Advisory Board; Janssen: Consultant; Janssen: Grant/Research Support; Merck & Co.: Consultant; Pfizer: Consultant; Prometheus Biosciences: Advisory Board; Prometheus Biosciences: Consultant; Sun Pharma: Consultant; Takeda: Consultant; Teva: Consultant
Robert Snyder: Has Nothing to Disclose.
Laura Swoboda: 3M: Consultant; Aroa: Consultant; AOTI: Consultant; Baxter: Consultant; ConvaTec: Consultant; Design for Vision: Consultant; Halyard: Consultant; Hartmann: Consultant; Histologics: Consultant; Innovacyn: Consultant; Smith & Nephew: Consultant; Solventum (Medical Surgical Business): Consultant; Urgo: Consultant
Tracey Vlahovic: Sagis Dx: Consultant
Amber Winske: Has Nothing to Disclose.
Heather C. Woolery-Lloyd: Allergan: Grant/Research Support; EPI Health: Speakers Bureau; Galderma: Grant/Research Support; Ortho Dermatologics: Speakers Bureau; Pfizer: Grant/Research Support; Somabella Laboratories, LLC: Major Stockholder
Brian S. Myer: Has Nothing to Disclose.
Susie Seaman, NP, MSN, CWCN, CWS (Nurse Planner)
Wound Clinic, Family Health Centers of San Diego
San Diego, California
Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).
HMP Education planners and staff include MaryEllen Fama; Avery Semler, MEd; Samantha Joy; Randy Robbin; and Andrea Zimmerman, EdD.
No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodation(s), please submit a request to contact the support team.
No commercial interest provided financial support for this continuing education activity. Please see each course for individual session support.
For immediate assistance, please explore our HMP Education Help Center or chat with our Virtual CE Assistant, which can answer most common questions related to claiming credits and the HMP Education website. If you have a question or grievance that cannot be answered by our Virtual CE assistant and Help Center, please submit a request to contact the support team. Our accreditation and compliance team will respond to your inquiry within one business day.
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own provider.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2026 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
